282 related articles for article (PubMed ID: 10704491)
1. Regulation of kinetic properties of GluR2 AMPA receptor channels by alternative splicing.
Koike M; Tsukada S; Tsuzuki K; Kijima H; Ozawa S
J Neurosci; 2000 Mar; 20(6):2166-74. PubMed ID: 10704491
[TBL] [Abstract][Full Text] [Related]
2. Differential modulation of AMPA receptors by cyclothiazide in two types of striatal neurons.
Vorobjev VS; Sharonova IN; Haas HL; Sergeeva OA
Eur J Neurosci; 2000 Aug; 12(8):2871-80. PubMed ID: 10971630
[TBL] [Abstract][Full Text] [Related]
3. Characterization of AMPA receptors on isolated amacrine-like cells in carp retina.
Shen Y; Zhou Y; Yang XL
Eur J Neurosci; 1999 Dec; 11(12):4233-40. PubMed ID: 10594649
[TBL] [Abstract][Full Text] [Related]
4. Control of kinetic properties of GluR2 flop AMPA-type channels: impact of R/G nuclear editing.
Krampfl K; Schlesinger F; Zörner A; Kappler M; Dengler R; Bufler J
Eur J Neurosci; 2002 Jan; 15(1):51-62. PubMed ID: 11860506
[TBL] [Abstract][Full Text] [Related]
5. Kinetic properties of human AMPA-type glutamate receptors expressed in HEK293 cells.
Grosskreutz J; Zoerner A; Schlesinger F; Krampfl K; Dengler R; Bufler J
Eur J Neurosci; 2003 Mar; 17(6):1173-8. PubMed ID: 12670305
[TBL] [Abstract][Full Text] [Related]
6. A desensitization-selective potentiator of AMPA-type glutamate receptors.
Sekiguchi M; Nishikawa K; Aoki S; Wada K
Br J Pharmacol; 2002 Aug; 136(7):1033-41. PubMed ID: 12145103
[TBL] [Abstract][Full Text] [Related]
7. Flip and flop: a molecular determinant for AMPA receptor channel opening.
Pei W; Huang Z; Wang C; Han Y; Park JS; Niu L
Biochemistry; 2009 May; 48(17):3767-77. PubMed ID: 19275243
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology of oligodendroglial excitotoxicity.
Yoshioka A; Bacskai B; Pleasure D
J Neurosci Res; 1996 Nov; 46(4):427-37. PubMed ID: 8950702
[TBL] [Abstract][Full Text] [Related]
9. Stable expression of recombinant AMPA receptor subunits: binding affinities and effects of allosteric modulators.
Hennegriff M; Arai A; Kessler M; Vanderklish P; Mutneja MS; Rogers G; Neve RL; Lynch G
J Neurochem; 1997 Jun; 68(6):2424-34. PubMed ID: 9166736
[TBL] [Abstract][Full Text] [Related]
10. Correlation of AMPA receptor subunit composition with synaptic input in the mammalian cochlear nuclei.
Gardner SM; Trussell LO; Oertel D
J Neurosci; 2001 Sep; 21(18):7428-37. PubMed ID: 11549753
[TBL] [Abstract][Full Text] [Related]
11. Allosteric regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionate receptors by thiocyanate and cyclothiazide at a common modulatory site distinct from that of 2,3-benzodiazepines.
Donevan SD; Rogawski MA
Neuroscience; 1998 Dec; 87(3):615-29. PubMed ID: 9758228
[TBL] [Abstract][Full Text] [Related]
12. Stargazin interaction with alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptors is critically dependent on the amino acid at the narrow constriction of the ion channel.
Körber C; Werner M; Hoffmann J; Sager C; Tietze M; Schmid SM; Kott S; Hollmann M
J Biol Chem; 2007 Jun; 282(26):18758-66. PubMed ID: 17483093
[TBL] [Abstract][Full Text] [Related]
13. Molecular determinants responsible for differences in desensitization kinetics of AMPA receptor splice variants.
Quirk JC; Siuda ER; Nisenbaum ES
J Neurosci; 2004 Dec; 24(50):11416-20. PubMed ID: 15601947
[TBL] [Abstract][Full Text] [Related]
14. Ethanol sensitivity of recombinant homomeric and heteromeric AMPA receptor subunits expressed in Xenopus oocytes.
Akinshola BE; Yasuda RP; Peoples RW; Taylor RE
Alcohol Clin Exp Res; 2003 Dec; 27(12):1876-83. PubMed ID: 14691374
[TBL] [Abstract][Full Text] [Related]
15. The norbornenyl moiety of cyclothiazide determines the preference for flip-flop variants of AMPA receptor subunits.
Kessler M; Rogers G; Arai A
Neurosci Lett; 2000 Jun; 287(2):161-5. PubMed ID: 10854736
[TBL] [Abstract][Full Text] [Related]
16. Stable expression of human homomeric and heteromeric AMPA receptor subunits in HEK293 cells.
Nishimura S; Iizuka M; Wakamori M; Akiba I; Imoto K; Barsoumian EL
Recept Channels; 2000; 7(2):139-50. PubMed ID: 10952090
[TBL] [Abstract][Full Text] [Related]
17. Disruption of agonist and ligand activity in an AMPA glutamate receptor splice-variable domain deletion mutant.
Johnson WD; Parandaman V; Onaivi ES; Taylor RE; Akinshola BE
Brain Res; 2008 Jul; 1222():18-30. PubMed ID: 18585685
[TBL] [Abstract][Full Text] [Related]
18. A binding site tyrosine shapes desensitization kinetics and agonist potency at GluR2. A mutagenic, kinetic, and crystallographic study.
Holm MM; Naur P; Vestergaard B; Geballe MT; Gajhede M; Kastrup JS; Traynelis SF; Egebjerg J
J Biol Chem; 2005 Oct; 280(42):35469-76. PubMed ID: 16103115
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological detection of AMPA receptor heterogeneity by use of two allosteric potentiators in rat hippocampal cultures.
Sekiguchi M; Takeo J; Harada T; Morimoto T; Kudo Y; Yamashita S; Kohsaka S; Wada K
Br J Pharmacol; 1998 Apr; 123(7):1294-303. PubMed ID: 9579722
[TBL] [Abstract][Full Text] [Related]
20. AMPA receptor flip/flop mutants affecting deactivation, desensitization, and modulation by cyclothiazide, aniracetam, and thiocyanate.
Partin KM; Fleck MW; Mayer ML
J Neurosci; 1996 Nov; 16(21):6634-47. PubMed ID: 8824304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
